Elanco Animal Health Inc
SWB:5EA
Elanco Animal Health Inc
SWB:5EA
Price:
21.185
EUR
1.17%
Market Cap:
€17.7B
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
E
|
Elanco Animal Health Inc
SWB:5EA
|
US |
|
Shenzhen Guangju Energy Co Ltd
SZSE:000096
|
CN |
|
COSCO Shipping Holdings Co Ltd
SSE:601919
|
CN |
|
F
|
Firm Capital Apartment Real Estate Investment Trust
XTSX:FCA.U
|
CA |
|
Nexgel Inc
NASDAQ:NXGL
|
US |
|
Coca-Cola Europacific Partners PLC
NASDAQ:CCEP
|
UK |
|
Saurer Intelligent Technology Co Ltd
SSE:600545
|
CN |
|
P
|
Proud Real Estate PCL
SET:PROUD
|
TH |
|
Saudi Telecom Company SJSC
SAU:7010
|
SA |
|
C
|
Computer and Technologies Holdings Ltd
HKEX:46
|
HK |
|
V
|
VRL Logistics Ltd
BSE:539118
|
IN |
|
S
|
S2Medical AB (publ)
STO:S2M
|
SE |
|
American Battery Materials Inc
OTC:BLTH
|
US |
|
Keyware Technologies NV
XBRU:KEYW
|
BE |
Relative Value
The Relative Value of one
5EA
stock under the Base Case scenario is
hidden
EUR.
Compared to the current market price of 21.185 EUR,
Elanco Animal Health Inc
is
hidden
.
Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Relative Valuation FAQ:
5EA Relative Value
HIDDEN
Multiples Across Competitors
5EA Competitors Multiples
Elanco Animal Health Inc Competitors
Elanco Animal Health Inc Competitors
All Countries
| Market Cap | P/S | P/E | EV/EBITDA | EV/EBIT | ||||
|---|---|---|---|---|---|---|---|---|
| US |
|
Elanco Animal Health Inc
SWB:5EA
|
12.4B EUR | 2.6 | -53.4 | 16.9 | 62.7 | |
| US |
|
Eli Lilly and Co
NYSE:LLY
|
853.2B USD | 13.1 | 41.3 | 27.9 | 29.8 | |
| US |
|
Johnson & Johnson
NYSE:JNJ
|
566.5B USD | 6 | 21.1 | 14.7 | 18.1 | |
| CH |
|
Roche Holding AG
SIX:ROG
|
243.4B CHF | 4 | 18.9 | 11.2 | 12.6 | |
| US |
|
Merck & Co Inc
NYSE:MRK
|
288B USD | 4.4 | 15.8 | 9.8 | 11.9 | |
| UK |
|
AstraZeneca PLC
LSE:AZN
|
214.2B GBP | 5 | 28.5 | 15.8 | 22.3 | |
| CH |
|
Novartis AG
SIX:NOVN
|
225.4B CHF | 5.2 | 21.1 | 13.1 | 16.8 | |
| IE |
E
|
Endo International PLC
LSE:0Y5F
|
237.1B USD | 102.3 | -81.1 | 375.3 | 941.3 | |
| DK |
|
Novo Nordisk A/S
CSE:NOVO B
|
1.1T DKK | 3.4 | 10.4 | 7.7 | 9.1 | |
| US |
|
Pfizer Inc
NYSE:PFE
|
153.3B USD | 2.4 | 19.7 | 7.6 | 10.1 | |
| US |
|
Bristol-Myers Squibb Co
NYSE:BMY
|
115.5B USD | 2.4 | 16.4 | 7 | 8.6 |
P/S Multiple
P/E Multiple
EV/EBITDA Multiple
EV/EBIT Multiple
